Koers Acro Biomedical Co., Ltd. Other OTC
Aandelen
ACBM
US0048921052
Voedselverwerking
Omzet 2021 | 1,2 mln. 1,1 mln. | Omzet 2022 | 658K 606K | Marktkapitalisatie | 270 mln. 249 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -7 mln. -6,44 mln. | Nettowinst (verlies) 2022 | -15 mln. -13,8 mln. | EV/omzet 2021 | 233 x |
Nettoliquiditeiten 2021 | 24,08K 22,15K | Nettoschuld 2022 | 98,69K 90,78K | EV/omzet 2022 | 410 x |
K/w-verhouding 2021 |
-32,5
x | K/w-verhouding 2022 |
-17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 50,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,16% | 8,44 mld. | |
+3,57% | 7,47 mld. | |
+6,50% | 6,31 mld. | |
-4,70% | 3,77 mld. | |
-6,75% | 3,73 mld. | |
-3,55% | 1,33 mld. | |
+14,40% | 988 mln. | |
-9,25% | 927 mln. | |
-17,08% | 801 mln. |